Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis is a research paper published in PLOS ONE (2022). On theSindex it has a DataRank of 0.500. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.500
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Prostate Cancer UK
Grant: RIA 16-ST2-020
National Institute for Health Research
Grant: NIHR301653
Medical Research Council
Grant: MC_UU_00004/06
Method Meta-analysis
National Institute for Health Research
Grant: NIHR-CS-2016-16-011
School for Social Care Research
Grant: RP-2015-06-018
World Health Organization
Grant: 001
National Institute for Health Research (NIHR)
Grant: Covid-19 - REMAP-CAP
Canadian Institutes of Health Research
Grant: unidentified
unidentified
European Commission
Grant: 101003589
Rapid European SARS-CoV-2 Emergency research Response
FWCI
2.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals